EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V.: EHC and Croma-Pharma GmbH, agree on adjusted enterprise value of Croma, and Sponsors waive 20% sponsor shares and devalue 20% sponsor warrants

EQS-Ad-hoc: European Healthcare Acquisition & Growth Company B.V. / Key word(s): Miscellaneous European Healthcare Acquisition & Growth Company B.V. and Croma-Pharma GmbH, agree on adjusted enterprise

Related Keywords

United States ,Munich ,Bayern ,Germany ,China ,New Zealand ,Frankfurt ,Brandenburg ,Brazil ,Austria ,Japan ,Australia ,United Kingdom ,Amsterdam ,Noord Holland ,Netherlands ,Canada ,Croma Pharma Gmb ,Croma Pharma Gmbh ,Kai Peter Rath ,Cornelius Baur ,Treuhand Gmb ,Distribution Services ,Securities Of The Company ,European Parliament ,Commission Delegated Directive ,Financial Services ,Securities Of European Healthcare Acquisition Growth Company ,News Service ,European Healthcare Acquisition Growth Company ,European Union Withdrawal ,European Healthcare Acquisition ,Healthcare Acquisition ,Market Abuse Regulation ,Sponsor Shares ,Sponsor Warrants ,Growth Company ,Croma Shareholders ,Prospectus Regulation ,European Union ,Markets Act ,Financial Promotion ,Relevant Persons ,Retail Investor ,Retail Investors ,Public Shares ,Public Warrants ,Regulatory Announcements ,Corporate News ,Unofficial Market ,Gefallene Big Techs ,Adhoc ,European ,Healthcare ,Cquisition ,Growth ,Company ,Roma ,Dharma ,Mbh ,Degree ,Djusted ,Enterprise ,Value ,Sponsors ,Waive ,Sponsor ,Hares ,Devalue ,Warrants ,